New Horizon Health Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
1,041
- Latest Deal Type
-
PIPE
- Latest Deal Amount
-
$113M
- Investors
-
18
New Horizon Health General Information
Description
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
Contact Information
Website
www.newhorizonbio.comCorporate Office
- Room 110, 1st Floor, Building 2, No. 475 Changhe Road
- Changhe Subdistrict, Binjiang District
- Hangzhou, Zhejiang
- China
Corporate Office
- Room 110, 1st Floor, Building 2, No. 475 Changhe Road
- Changhe Subdistrict, Binjiang District
- Hangzhou, Zhejiang
- China
New Horizon Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. PIPE | 18-Jan-2023 | $113M | Completed | Generating Revenue | ||
| 7. IPO | 17-Feb-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series E) | 01-Jul-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 15-May-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 15-Apr-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A2) | 29-Dec-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 16-Jun-2017 | $20M | $34M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A1) | 30-Dec-2015 | $14M | $14M | Completed | Startup |
New Horizon Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
New Horizon Health Patents
New Horizon Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024104396-A1 | Method for detecting diseases such as cancer using relative family proportion of mirna subtype | Inactive | 15-Nov-2022 | ||
| WO-2024099301-A1 | Detection and analysis of signals of positive and negative strands of cell-free dna molecule | Inactive | 09-Nov-2022 | ||
| EP-4534666-A1 | Method and reagent for nucleic acid extraction and purification using porous nanomaterial | Pending | 27-May-2022 | ||
| EP-4534666-A4 | Method and reagent for nucleic acid extraction and purification using porous nanomaterial | Pending | 27-May-2022 | ||
| US-20250354136-A1 | Method and reagent for nucleic acid extraction and purification using porous nanomaterial | Pending | 27-May-2022 | C12N15/1013 |
New Horizon Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
New Horizon Health Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boyu Capital | Asset Manager | Minority | ||
| Columbia Threadneedle Investments | Asset Manager | Minority | ||
| E Fund Management (HK) | Asset Manager | Minority | ||
| GIC Private | Sovereign Wealth Fund | Minority | ||
| Hudson Bay Capital Management | Asset Manager | Minority |
New Horizon Health Investments (2)
New Horizon Health’s most recent deal was a Seed Round with Orbit Genomics for . The deal was made on 06-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Orbit Genomics | 06-Jan-2022 | Seed Round | Biotechnology | ||
| ProteoMediX | 21-Sep-2021 | Later Stage VC | Diagnostic Equipment |
New Horizon Health ESG
Risk Overview
Risk Rating
Updated February, 28, 2023
26.18 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,271
Rank
Percentile
Healthcare
Industry
of 614
Rank
Percentile
Medical Services
Subindustry
of 100
Rank
Percentile
New Horizon Health Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| NHH Ventures | Hong Kong, Hong Kong | 2021 |
New Horizon Health FAQs
-
When was New Horizon Health founded?
New Horizon Health was founded in 2015.
-
Where is New Horizon Health headquartered?
New Horizon Health is headquartered in Hangzhou, China.
-
What is the size of New Horizon Health?
New Horizon Health has 1,041 total employees.
-
What industry is New Horizon Health in?
New Horizon Health’s primary industry is Laboratory Services (Healthcare).
-
Is New Horizon Health a private or public company?
New Horizon Health is a Private company.
-
What is New Horizon Health’s current revenue?
The current revenue for New Horizon Health is .
-
How much funding has New Horizon Health raised over time?
New Horizon Health has raised $542M.
-
Who are New Horizon Health’s investors?
Boyu Capital, Columbia Threadneedle Investments, E Fund Management (HK), GIC Private, and Hudson Bay Capital Management are 5 of 18 investors who have invested in New Horizon Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
